Syneron Medical Ltd.'s elure™ Wins Allure Magazine's BEST OF BEAUTY Award For The Fourth Consecutive Year
YOKNEAM, Israel, Sept. 15, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), the global leader in medical aesthetic products and technology, announced today that Allure Magazine has named elure Advanced Brightening Lotion its "Best Anti-Ager for Discoloration" in its annual Best of Beauty issue, which is published in October every year. This is the fourth consecutive win for elure in Allure Magazine's Best of Beauty issue. elure has earned this honor each year since launching in 2011 when it was recognized in the prestigious "Big Breakthroughs" category.
Allure Magazine selects winners based on real, noticeable results. Among the thousands of beauty products launched every year, these are the products that stand out as tried and tested editor favorites for their incredible efficacy.
"We are proud to earn consecutive recognition for our industry-leading brightening from Allure, a publication we hold in high regard," said Amit Meridor, Chief Executive Officer of Syneron. "elure represents the next generation in skin brightening products with proven clinical results and a superior safety profile, which underscores our commitment to pioneering innovative aesthetic solutions and technological advancements."
elure Advanced Brightening Lotion contains the patented technology Melanozyme, which is a naturally occurring mushroom-derived enzyme that works to brighten skin safely and effectively. Melanozyme breaks down existing discoloration, without the irritation and side effects of harsh prescription topicals. A noticeable change in skin's radiance, texture, tone and overall appearance can be seen in as little as four weeks, making it the go-to gold standard skin brightening product for physicians and editors alike.
See elure Advanced Brightening Lotion's Best of Beauty award for "Best Anti-Ager for Discoloration" in Allure Magazine's October 2014 issue.
See elure Lotion highlighted as one of Allure Magazine's tops ways to "Get Seriously Radiant Skin" here: http://www.allure.com/beauty-products/2014/how-to-get-seriously-radiant-skin#slide=3
For more information about elure's full range of products visit www.elureskin.com or follow us on Facebook: http://www.facebook.com/elureskin.
About Syneron Medical Ltd.
Syneron Medical Ltd. a company devoted to real technology, real science and real results is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. With its innovative approach to aesthetic treatments, Syneron has now entered into one of the largest in-demand applications, skin brightening. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The company markets and services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.
elure is sold as a topical cosmetic intended to beautify your skin and cosmetics are not subject to evaluation by the FDA. All product information provided is intended to be for informational purposes only. The information about skin conditions provided herein does not constitute medical or pharmaceutical advice and should not be relied upon as a substitute for qualified medical consultation with health professionals.
Additional information can be found at www.syneron.com
Photo - http://photos.prnewswire.com/prnh/20140915/146139
SOURCE Syneron Medical Ltd.